http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10506905-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 1995-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10506905-A |
| titleOfInvention | Naphthyridine derivative |
| abstract | (57) [Summary] Formula I: [In the formula, R 1, C 1 -C 6 - alkyl group; R 2 is the formula COOR 4 (wherein, R 4 is C 1 -C 5 - alkyl represents a group) represent a group; and R 3 It is (wherein, R 5 is C 1 -C 5 - alkyl represents a group) wherein COOR 5 compounds and acceptable salts thereof pharmaceutically in a group of] are disclosed, they have anti-rheumatic drugs It is also useful as an agent for reducing cytokine synthesis, an immunomodulator, an anti-inflammatory agent and an anti-allergic agent. Also disclosed are compositions containing these compounds and methods for making these compounds. |
| priorityDate | 1994-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.